Literature DB >> 17870166

The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.

Ke Li1, Steven H Sacks, Neil S Sheerin.   

Abstract

Urinary tract infection due to uropathogenic Escherichia coli is a common clinical problem. The innate immune system and the uroepithelium are critical in defence against infection. The complement system is both part of the innate immune system and influences the interaction between epithelium and pathogen. We have therefore investigated the mechanism by which uropathogenic E. coli activate complement and the potential for this to occur during clinical infection. The classical pathway is responsible for bacterial opsonisation when complement proteins are present at low concentrations. At higher concentrations the alternative pathway predominates but still requires the classical pathway for its initiation. In contrast the mannose binding lectin pathway is not involved. Early classical pathway components are present in the urine during infection and actively contribute to bacterial opsonisation. The classical pathway could be initiated by anti-E. coli antibodies of IgG or IgM subclasses that are present in urine during infection. Additionally immunoglobulin-independent mechanisms, such as direct C1q binding to bacteria, may be involved. In conclusion, uropathogenic E. coli are readily opsonised by complement in a classical pathway dependent manner. This can occur within the urinary tract during the development of clinical infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17870166     DOI: 10.1016/j.molimm.2007.07.037

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  15 in total

1.  NlpI facilitates deposition of C4bp on Escherichia coli by blocking classical complement-mediated killing, which results in high-level bacteremia.

Authors:  Yu-ting Tseng; Shainn-Wei Wang; Kwang Sik Kim; Ying-Hsiang Wang; Yufeng Yao; Chien-Cheng Chen; Chi-Wu Chiang; Pao-Chuan Hsieh; Ching-Hao Teng
Journal:  Infect Immun       Date:  2012-07-16       Impact factor: 3.441

2.  Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis.

Authors:  Gregory G Anderson; Carlos C Goller; Sheryl Justice; Scott J Hultgren; Patrick C Seed
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

3.  The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli.

Authors:  Irina Debnath; J Paul Norton; Amelia E Barber; Elizabeth M Ott; Bijaya K Dhakal; Richard R Kulesus; Matthew A Mulvey
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

4.  High-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agents.

Authors:  Carlos C Goller; Patrick C Seed
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

5.  Proteomics of Urinary Vesicles Links Plakins and Complement to Polycystic Kidney Disease.

Authors:  Mahdi Salih; Jeroen A Demmers; Karel Bezstarosti; Wouter N Leonhard; Monique Losekoot; Cees van Kooten; Ron T Gansevoort; Dorien J M Peters; Robert Zietse; Ewout J Hoorn
Journal:  J Am Soc Nephrol       Date:  2016-03-03       Impact factor: 10.121

6.  Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance.

Authors:  Eric L Buckles; Xiaolin Wang; M Chelsea Lane; C Virginia Lockatell; David E Johnson; David A Rasko; Harry L T Mobley; Michael S Donnenberg
Journal:  J Infect Dis       Date:  2009-06-01       Impact factor: 5.226

7.  Diagnosing inflammation and infection in the urinary system via proteomics.

Authors:  Yanbao Yu; Patricia Sikorski; Cynthia Bowman-Gholston; Nicolas Cacciabeve; Karen E Nelson; Rembert Pieper
Journal:  J Transl Med       Date:  2015-04-08       Impact factor: 5.531

8.  Lifting the mask: identification of new small molecule inhibitors of uropathogenic Escherichia coli group 2 capsule biogenesis.

Authors:  Carlos C Goller; Mehreen Arshad; James W Noah; Subramaniam Ananthan; Carrie W Evans; N Miranda Nebane; Lynn Rasmussen; Melinda Sosa; Nichole A Tower; E Lucile White; Benjamin Neuenswander; Patrick Porubsky; Brooks E Maki; Steven A Rogers; Frank Schoenen; Patrick C Seed
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

9.  Synergy between type 1 fimbriae expression and C3 opsonisation increases internalisation of E. coli by human tubular epithelial cells.

Authors:  Ke Li; Wuding Zhou; Yuzhi Hong; Steven H Sacks; Neil S Sheerin
Journal:  BMC Microbiol       Date:  2009-03-31       Impact factor: 3.605

10.  Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells.

Authors:  Eveline C van Asbeck; Andy I M Hoepelman; Jelle Scharringa; Bjorn L Herpers; Jan Verhoef
Journal:  BMC Microbiol       Date:  2008-12-18       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.